Liang Zhang

Dr. Liang Zhang

orcid

Research Focus & Metrics

Academic Career Length

10Years (2017-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
29 November 2018 in BMC Cancer
Verified
Journal Article
Open access
PDF file
QBQiaowen Bu
Qiaowen Bu
SWSanfeng Wang
Sanfeng Wang
JMJian Ma
Jian Ma
XZXiangcheng Zhou
Xiangcheng Zhou
GHGuiying Hu
Guiying Hu
XLXiping Luo
Xiping Luo
To explore the diagnostic value of FAM19A4 methylation in high-risk human papilloma virus (hrHPV)-positive cervical samples from Chinese women for estimating cervical cancer or its precancerous lesions. Cervical samples from 215 women infected with high-risk HPV were collected by smear testing. We purposely chose 61 patients with cervical cancer, 57 with high-grade squamous intraepithelial lesions (HSIL), 31 with low-grade squamous intraepithelial lesions (LSIL), and 66 without cervical intraepithelial neoplasia (CIN) after histological confirmation. Taqman probe-based quantitative PCR (qPCR) was utilized to detect the methylation status of FAM19A4 in the cervical samples and further evaluate the use of this gene in the diagnosis of cervical cancer. (1) An increasing level of FAM19A4 methylation was detected with increasing progression of cervical lesions, with methylation rates of 10.61%(7/66), 35.48%(11/31), 56.14%(32/57) and 93.44%(57/61) in no CIN, LSIL, HSIL and cervical carcinoma samples respectively. (2) In all hrHPV-positive samples, the levels of FAM19A4 methylation in HPV16/18 groups were higher than that in 12 other hrHPV groups (P < 0.05), but there was no significant difference between two groups after grouping cervical lesions into cervical cancer, HSIL, LSIL and no CIN groups (P>0.05). (3)There were no significant differences of FAM19A4 methylation in different clinicopathological parameters of cervical cancer. (4) Though the sensitivity of FAM19A4 methylation test was inferior to that of cytology and FAM19A4 combining with HPV16/18 genotyping, but showed the best specificity with 81.44% both for detection HSIL alone and ≥ HSIL, with favorable youden index (YI) and area under curve (AUC). FAM19A4 is a specific biomarker of cancerous lesions of the cervix. FAM19A4 methylation analysis may serve as an auxiliary screening method for diagnosis of cervical (pre)cancer. However, in consideration of the limitations of this retrospective study, prospective population-based studies are necessary for further confirmation of the diagnostic value of FAM19A4 methylation for detection of cervical (pre)cancer in Chinese women.

6 February 2023 in Frontiers in Microbiology
Verified
Journal Article
Open access
XXXuan Xiao
Xuan Xiao
SLShangfeng Liu
Shangfeng Liu
HDHua Deng
Hua Deng
YSYuhan Song
Yuhan Song
LZLiang Zhang
Liang Zhang
ZSZhifeng Song
Zhifeng Song
Several studies have shown that the dysregulation of the oral microbiota plays a crucial role in human health conditions, such as dental caries, periodontal disease, oral cancer, other oral infectious diseases, cardiovascular diseases, diabetes, bacteremia, and low birth weight. The use of traditional detection methods in conjunction with rapidly advancing molecular techniques in the diagnosis of harmful oral microorganisms has expanded our understanding of the diversity, location, and function of the microbiota associated with health and disease. This review aimed to highlight the latest knowledge in this field, including microbial colonization; the most modern detection methods; and interactions in disease progression. The next decade may achieve the rapid diagnosis and precise treatment of harmful oral microorganisms.

20 December 2017 in Gynecological Endocrinology
Verified
Journal Article
Closed access
NSNian-Jun Su
Nian-Jun Su
JMJian Ma
Jian Ma
DFDe-Feng Feng
De-Feng Feng
SZShuai Zhou
Shuai Zhou
ZLZi-Tao Li
Zi-Tao Li
LZLiang Zhang
Liang Zhang
Polycystic ovary syndrome (PCOS) is a common endocrine disorder in women, resulting in ovulation failure and other metabolic problems. However, the underlying mechanisms of it remain largely uncertain due to the complexity of clinical manifestations. This systemic disorder is involved in endocrine, metabolism, immune system and many organs, and few studies have explored peripheral blood transcriptome in patients with PCOS. We performed gene expression profiling of peripheral blood from 8 PCOS patients and eight healthy women with microarray. The significance analysis of microarray (SAM) software was employed to screen the differentially expressed genes (DEGs) and gene ontology (GO) was used for functional enrichment analysis. In total, 181 DEGs with fold-changes >2.0 and q-values <0.05 were identified between the two groups. Among them, 149 were up-regulated and 32 down-regulated in PCOS. Unsupervised clustering of expressed genes could readily differentiate PCOS from control. More importantly, inflammatory response pathway including 14 dysregulated genes was highly enriched in PCOS. Furthermore, 10 DEGs were validated using quantitative reverse-transcription PCR (qRT-PCR) assays. Our study provides independent evidence for the involvement of systemic inflammatory response in PCOS and it may facilitate a greater understanding of this complex disease.

29 June 2020 in BMC Cardiovascular Disorders
Verified
Journal Article
Open access
PDF file
QLQin Liu
Qin Liu
JMJian Ma
Jian Ma
HDHua Deng
Hua Deng
SHShu-Jun Huang
Shu-Jun Huang
JRJiao Rao
Jiao Rao
LZLiang Zhang
Liang Zhang
Background: Correct detection of human cardiomyocyte death is essential for definitive diagnosis and appropriate management of cardiovascular diseases. Although current strategies have proven utility in clinical cardiology, they have some limitations. Our aim was to develop a new approach to monitor myocardial death using methylation patterns of circulating cell-free DNA (cf-DNA). Methods: We first examined the methylation status of FAM101A in heart tissue and blood of individual donors using quantitative methylation-sensitive PCR (qMS-PCR). The concentrations and kinetics of cardiac cf-DNA in plasma from five congenital heart disease (CHD) children before and after they underwent cardiac surgery at serial time points were then investigated. Results: We identified demethylated FAM101A specifically present in heart tissue. Importantly, our time course experiments demonstrated that the plasma cardiac cf-DNA level increased quickly during the early post-cardiac surgery phase, peaking at 4–6 h, decreased progressively (24 h) and returned to baseline (72 h). Moreover, cardiac cf-DNA concentrations pre- and post-operation were closely correlated with plasma troponin levels. Conclusions: We proposed a novel strategy for the correct detection of cardiomyocyte death, based on analysis of plasma cf-DNA carrying the cardiac-specific methylation signature. Our pilot study may lead to new tests for human cardiac pathologies.

1 September 2018 in Journal of Pediatric Surgery
Verified
Journal Article
Closed access
SXShang-Jie Xiao
Shang-Jie Xiao
XZXiao-Chun Zhu
Xiao-Chun Zhu
HDHua Deng
Hua Deng
WZWei-Ping Zhou
Wei-Ping Zhou
WYWen-Yi Yang
Wen-Yi Yang
HXHuimin Xia
Huimin Xia

1 November 2019 in International Journal of Pediatric Otorhinolaryngology
Verified
Journal Article
Closed access
YZYu Zou
Yu Zou
QDQi-Qiang Dai
Qi-Qiang Dai
WTWei-Jing Tao
Wei-Jing Tao
XWXiao-Ling Wen
Xiao-Ling Wen
DFDe-Feng Feng
De-Feng Feng
LZLiang Zhang
Liang Zhang